Nanomedicine uses structures and devices that are typically 1 to 100 nanometers in size to help diagnose, monitor, and treat disease. At this scale, materials can interact with cells, proteins, and DNA in highly specific ways. This matters because many diseases begin with molecular changes long before they cause visible symptoms.
Nanoscale tools can improve precision by delivering signals or medicines directly where they are needed.
A nanomedical device may include a protective shell, a polymer coating, targeting ligands, sensors, and a drug payload. Targeting ligands can bind to molecules found on diseased cells, while the coating helps the device circulate through blood without being removed too quickly. Some nanoparticles release medicine when they detect triggers such as low pH, specific enzymes, heat, or light.
This approach can increase the dose at the diseased tissue while reducing damage to healthy cells.
Key Facts
- 1 nanometer = 1 x 10^-9 m.
- Many nanomedicine systems are about 1 to 100 nm in size.
- Drug dose delivered to a tissue can be estimated by dose = concentration x volume.
- Targeting improves specificity by using ligand receptor binding between the device and diseased cells.
- Surface area to volume ratio increases as particle size decreases, which can make nanoparticles more reactive.
- Controlled release can be triggered by conditions such as pH, temperature, enzymes, magnetic fields, or light.
Vocabulary
- Nanomedicine
- Nanomedicine is the use of nanoscale materials or devices to diagnose, monitor, prevent, or treat disease.
- Nanoparticle
- A nanoparticle is a tiny particle, usually between 1 and 100 nanometers wide, designed to carry or interact with biological materials.
- Targeting ligand
- A targeting ligand is a molecule attached to a nanodevice that binds to a specific receptor on a cell.
- Drug payload
- A drug payload is the medicine carried inside or attached to a delivery device for release at a target site.
- Controlled release
- Controlled release is the planned release of a drug over time or in response to a specific biological trigger.
Common Mistakes to Avoid
- Thinking nanomedicine means tiny robots with human-like control. Most current nanomedicine uses engineered particles, coatings, sensors, and chemical targeting rather than independent robotic machines.
- Assuming smaller particles are always safer. Nanoscale materials can enter tissues differently and may cause toxicity if their chemistry, dose, or clearance is not carefully designed.
- Ignoring the immune system. A nanoparticle that looks foreign can be removed quickly by immune cells, reducing its ability to reach the target tissue.
- Confusing targeting with perfect accuracy. Targeting ligands increase the chance of binding to diseased cells, but some particles may still reach healthy tissues or be filtered by the liver, spleen, or kidneys.
Practice Questions
- 1 A drug delivery nanoparticle has a diameter of 80 nm. What is its diameter in meters using scientific notation?
- 2 A nanocapsule releases a drug at a rate of 0.25 micrograms per hour. How much drug is released in 12 hours?
- 3 A cancer cell has a receptor that is rare on healthy cells but common on tumor cells. Explain why adding a matching targeting ligand to a nanomedicine device could improve treatment precision.